PH20100A - Process for the manufacture of chiral aldehydes - Google Patents

Process for the manufacture of chiral aldehydes

Info

Publication number
PH20100A
PH20100A PH30297A PH30297A PH20100A PH 20100 A PH20100 A PH 20100A PH 30297 A PH30297 A PH 30297A PH 30297 A PH30297 A PH 30297A PH 20100 A PH20100 A PH 20100A
Authority
PH
Philippines
Prior art keywords
general formula
above significance
see diagramm
formula see
reacting
Prior art date
Application number
PH30297A
Other languages
English (en)
Inventor
Christian Dr Hubschwerlen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH20100A publication Critical patent/PH20100A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH30297A 1983-02-25 1984-02-24 Process for the manufacture of chiral aldehydes PH20100A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH106183 1983-02-25
CH3384 1984-01-05

Publications (1)

Publication Number Publication Date
PH20100A true PH20100A (en) 1986-09-24

Family

ID=25683311

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30297A PH20100A (en) 1983-02-25 1984-02-24 Process for the manufacture of chiral aldehydes

Country Status (9)

Country Link
EP (1) EP0120289B1 (da)
AT (1) ATE34389T1 (da)
AU (1) AU570032B2 (da)
CA (1) CA1224789A (da)
DE (1) DE3471306D1 (da)
DK (1) DK36784A (da)
IL (1) IL71006A (da)
NZ (1) NZ207193A (da)
PH (1) PH20100A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251454A (en) * 1983-01-20 1989-03-21 Gerard Schmid PROCESS FOR THE MANUFACTURE OF .beta.-LACTAMES
DK411384A (da) * 1983-10-03 1985-04-04 Hoffmann La Roche Fremgangsmaade til fremstilling af azetidinonderivater
IL101052A (en) * 1991-02-28 1997-03-18 Lilly Co Eli Process for producing glyceraldehyde- 3-pentanide
US9296735B2 (en) 2012-05-18 2016-03-29 Amgen Inc. Method for the preparation of thiadiazoles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2541438A1 (de) * 1975-09-17 1977-03-31 Basf Ag Dioxolanaldehyde und verfahren zu ihrer herstellung
US4111958A (en) * 1977-06-03 1978-09-05 Pfizer Inc. Ascorbic acid synthesis
CA1262128A (en) * 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
DE3372768D1 (de) * 1982-06-03 1987-09-03 Hoffmann La Roche 1-sulfo-2-oxoazetidine derivatives
CA1204746A (en) * 1982-08-19 1986-05-20 Hoffmann-La Roche Limited .beta. LACTAMS
CA1251454A (en) * 1983-01-20 1989-03-21 Gerard Schmid PROCESS FOR THE MANUFACTURE OF .beta.-LACTAMES

Also Published As

Publication number Publication date
ATE34389T1 (de) 1988-06-15
AU570032B2 (en) 1988-03-03
IL71006A (en) 1988-10-31
EP0120289A3 (en) 1985-01-23
CA1224789A (en) 1987-07-28
AU2474584A (en) 1984-08-30
NZ207193A (en) 1987-10-30
IL71006A0 (en) 1984-05-31
DK36784D0 (da) 1984-01-26
DE3471306D1 (en) 1988-06-23
DK36784A (da) 1984-08-26
EP0120289A2 (de) 1984-10-03
EP0120289B1 (de) 1988-05-18

Similar Documents

Publication Publication Date Title
CA1262357A (en) N-HYDROXYL PROTECTIVE GROUPS AND METHOD FOR THE PREPARATION OF 3-ACYLAMINO-1-HYDROXY-2-AZETIDINONES
EG18409A (en) Process for preparing rebeccamycin analogs
AU1576483A (en) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines
CY2078B1 (en) Methods of synthesizing benign prostatic hypertrophic agents
IL71006A0 (en) Manufacture of chiral aldehydes
ES8502071A1 (es) Un procedimiento mejorado para producir etilenglicol
EP0245631A3 (en) New chemical process for the preparation of oxamide derivatives and compounds prepared thereby
GB1424430A (en) 2,2,7,7-tetramethyl-1,4-diazacycloheptane derivatives
HUT40408A (en) Process for preparing trans-4-substituted s-prolines
YU131482A (en) Process for obtaining 6,7-diethoxy-(4-ethoxy-3-hydroxy-benzy)-3,4-dihydro-isoquinoline
IL63008A0 (en) Hydrocarbon soluble sodium alkyls and their manufacture
YU195185A (en) Process for preparing derivatives of aminobenzamide
DE3373650D1 (en) Process for the production of ethylene glycol
CA2274530A1 (en) Process for producing 5-arylthio imidazole derivatives
CA1273347C (da)
ES458153A1 (es) Un procedimiento para la preparacion de compuestos de imida-zol sustituidos.
ES472897A1 (es) Metodo de preparar derivados de antraquinona
AU540505B2 (en) Di alkylamines
KR970006247B1 (en) Novel benzothiazole derivatives and process for preparing the same
MY100148A (en) Process for preparing 1 , 5 - benzothiazepine derivatives
HU904596D0 (en) Process for producing lankacidine-carbaminate derivatives
ES436145A1 (es) Procedimiento para la obtencion de un derivado heterocicli- co.
EP0041576A4 (en) 1- (2,6-DICHLORPHENYL) -2-QUINOLINONE-IMIN-3-CARBOXYLIC ACID, PRODUCTION OF THE COMPOUND AND CONTAINING PAIN-RELIEFING, ANTI-FLAMMING COMPOSITION.